United Therapeutics Corp (UTHR) — 10-Q Filings
All 10-Q filings from United Therapeutics Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
United Therapeutics Posts Strong Q3 Revenue, Net Income Growth
— Oct 29, 2025 Risk: medium
United Therapeutics Corporation reported robust financial performance for the three and nine months ended September 30, 2025. Total revenues increased by 6.7% t -
United Therapeutics Posts Strong Q2 Growth, Net Income Jumps 21.6%
— Jul 30, 2025 Risk: medium
UNITED THERAPEUTICS Corp reported robust financial performance for the second quarter ended June 30, 2025, with significant growth in revenue and net income. Re -
United Therapeutics Files Q1 2025 10-Q
— Apr 30, 2025 Risk: low
United Therapeutics Corp. filed a 10-Q for the period ending March 31, 2025. The filing details financial information and business operations for the first quar -
United Therapeutics Q3 2024 Filing Released
— Oct 30, 2024 Risk: medium
United Therapeutics Corp. reported its third-quarter financial results for the period ending September 30, 2024. The company's filing details its financial posi -
United Therapeutics Files Q2 2024 10-Q
— Jul 31, 2024 Risk: medium
United Therapeutics Corp. filed its 10-Q for the period ending June 30, 2024. The company reported its financial performance for the second quarter and the firs -
United Therapeutics Corp Files 10-Q for Period Ending March 31, 2024
— May 1, 2024 Risk: low
UNITED THERAPEUTICS Corp (UTHR) filed a Quarterly Report (10-Q) with the SEC on May 1, 2024. United Therapeutics Corp filed a 10-Q report for the period ending
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX